Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody

Completed · Phase 4 · Has a placebo group

Conditions studied: Chronic Idiopathic Urticaria

In brief

Study to determine the efficacy of benralizumab when compared to placebo in patients with chronic hives that do not respond to antihistamine treatment

Key facts

Study ID

NCT03183024

Run by

Jonathan A. Bernstein, MD

People needed

12

Starts

2017-09-12

Expected to finish

2018-11-06

Last updated by the study team

2019-07-10

Who can join

Age: 19 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• hives for over 6 weeks of unknown cause hives most days of the despite use of antihistamines

You may not qualify if…

• hives due to known reasons history of cancer pregnant or nursing History of HIV or Hepatitis recent parasitic infection currently or have received treatment with a monoclonal antibody

Where it is running

• Bernstein Clinical Research Center — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.